Paid Clinical Trials Santa Ana

Discover 3,374 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 3,374

Elacestrant, CombinationOpen-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Stemline Therapeutics, Inc.

Location:

Los Alamitos CA, Whittier CA, Arcadia CA, Los Angeles CAshow 37 more

Code:

NCT05563220

Conditions

Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elacestrant

Alpelisib

Everolimus

Ribociclib

Palbociclib

ABBV-453A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Recruiting

PHASE1

Sponsor:

AbbVie

Location:

Irvine CA, Duarte CA, Billings MT, Houston TXshow 1 more

Code:

NCT06291220

Conditions

Chronic Lymphocytic Leukemia

Small Lymphocytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Obinutuzumab

ABBV-453

EVO756A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults with Chronic Inducible Urticaria

Recruiting

PHASE2

Sponsor:

Evommune, Inc.

Location:

Los Angeles CA, San Diego CA, Sacramento CA, Boise IDshow 14 more

Code:

NCT06603220

Conditions

Chronic Inducible Urticaria

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Oral EVO756

VedolizumabA Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Recruiting

PHASE3

Sponsor:

Takeda

Location:

Los Angeles CA, San Diego CA, Phoenix AZ, San Francisco CAshow 22 more

Code:

NCT04779320

Conditions

Crohn's Disease (CD)

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

Vedolizumab IV

Observational StudyThe PEERLESS II Study

Recruiting

Sponsor:

Inari Medical

Location:

Pasadena CA, Aurora CO, Spokane WA, Seattle WAshow 45 more

Code:

NCT06055920

Conditions

Pulmonary Embolism

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FlowTriever System

Anticoagulation Agents

Single vs. MultipleComparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Recruiting

Sponsor:

Weill Medical College of Cornell University

Location:

Pomona CA, Los Angeles CA, San Francisco CA, Salt Lake City UTshow 45 more

Code:

NCT04124120

Conditions

Heart Diseases

Coronary Artery Disease

Coronary Artery Bypass Grafting

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Single arterial graft

Multiple arterial grafting

RMC-6236Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Recruiting

PHASE3

Sponsor:

Revolution Medicines, Inc.

Location:

Los Angeles CA, San Diego CA, Phoenix AZ, Gilbert AZshow 17 more

Code:

NCT06625320

Conditions

Pancreatic Cancer

PDAC

PDAC - Pancreatic Ductal Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RMC-6236

Gemcitabine

nab-paclitaxel

Irinotecan

Liposomal irinotecan

MET233 & MET097A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

Recruiting

PHASE1

Sponsor:

Metsera

Location:

Cypress CA

Code:

NCT06924320

Conditions

Obesity and Obesity-related Medical Conditions

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

MET233 and MET097

Placebo

MET233

N-acetylcysteineOral N-acetylcysteine for Retinitis Pigmentosa

Recruiting

PHASE3

Sponsor:

Johns Hopkins University

Location:

Los Angeles CA, Stanford CA, San Francisco CA, Davis CAshow 21 more

Code:

NCT05537220

Conditions

Retinitis Pigmentosa

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

N-acetylcysteine

Placebo

BemarituzumabA Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Recruiting

PHASE1

PHASE2

Sponsor:

Amgen

Location:

Orange CA, Duarte CA, Aurora CO, Irving TXshow 9 more

Code:

NCT05325866

Conditions

Solid Tumors

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bemarituzumab